My thoughts on this are,We should get better sales data for this...

  1. 477 Posts.
    lightbulb Created with Sketch. 405
    My thoughts on this are,
    We should get better sales data for this quarter. 2 months out.

    if IPD meets its prescribed targets then SKW will release the second trance & IPD can take that funding if they wish.
    This is 3 months away. Include in this time frame if the CEO & CFO achieve their Transformation Bonus.

    5 months out continued sales momentum. 26Q1.

    The other item is the interest only period - inside that time frame is where the expected cash burn is gone or reduced to the extend it is longer an issue.

    Highlights for me are
    Director Bones from Google.
    Pathway & Funding implemented to stop the cycle of CRs.
    Enough coverage to achieve goals, no further reliance on the unknown policy change- note this will be a tailwind when they do change.
    Looking at other avenues to partner with other organizations to further SOZO functions similar to the AstraZeneca Renal Trials (income producing rather than CR, 75M raised for Heart that achieved no discernable outcome)

    Accumulate-where do you think the business will be at in 18-24 months.
    Acclivity
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
3.0¢
Change
-0.001(3.23%)
Mkt cap ! $60.82M
Open High Low Value Volume
3.0¢ 3.0¢ 3.0¢ $6.432K 214.4K

Buyers (Bids)

No. Vol. Price($)
5 91954 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
3.1¢ 270442 3
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
IPD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.